MARKET

MIRM

MIRM

Mirum Pharmaceuticals
NASDAQ
69.00
+1.95
+2.91%
After Hours: 67.67 -1.33 -1.93% 18:04 12/17 EST
OPEN
66.63
PREV CLOSE
67.05
HIGH
69.20
LOW
66.63
VOLUME
856.97K
TURNOVER
--
52 WEEK HIGH
78.54
52 WEEK LOW
36.88
MARKET CAP
3.57B
P/E (TTM)
-80.1115
1D
5D
1M
3M
1Y
5Y
1D
Mirum Pharmaceuticals Is Maintained at Buy by Stifel
Dow Jones · 1d ago
Mirum Pharmaceuticals Price Target Raised to $98.00/Share From $92.00 by Stifel
Dow Jones · 1d ago
Stifel Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $98
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Novan (NOVN) and Argenx Se (ARGX)
TipRanks · 1d ago
Weekly Report: what happened at MIRM last week (1208-1212)?
Weekly Report · 2d ago
Mirum Pharmaceuticals Grants Stock Options and RSUs to New Employees
Reuters · 12/11 00:00
MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 12/11 00:00
Mirum Pharmaceuticals price target raised to $100 from $90 at Leerink
TipRanks · 12/10 20:15
More
About MIRM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the treatment of rare diseases affecting children and adults. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal or Ctexli (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. The Company is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.

Webull offers Mirum Pharmaceuticals Inc stock information, including NASDAQ: MIRM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRM stock methods without spending real money on the virtual paper trading platform.